01 4Ozurdex
02 1Ozurdex?
03 1Tobramycin/ Dexamethasone
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 472
2022 Revenue in Millions : 428
Growth (%) : 10
Main Therapeutic Indication : Ophthalmology
Currency : USD
2017 Revenue in Millions : 312
2016 Revenue in Millions : 263
Growth (%) : 18
Main Therapeutic Indication : Ophthalmology
Currency : USD
2018 Revenue in Millions : 299
2017 Revenue in Millions : 312
Growth (%) : -4%
Main Therapeutic Indication : Ophthalmology
Currency : USD
2016 Revenue in Millions : 263
2015 Revenue in Millions : 168
Growth (%) : 57
Main Therapeutic Indication : Ophthalmology
Currency : USD
2019 Revenue in Millions : 400
2018 Revenue in Millions : 299
Growth (%) : 34
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 33
2019 Revenue in Millions : 31
Growth (%) : 6
LOOKING FOR A SUPPLIER?